Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

NCT00869999 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators